Aquis weekly movers: Hydrogen Utopia US trading facility and Lekoil returns from suspension

Waste plastic to hydrogen business Hydrogen Utopia International (LON: HUI) was the best performing Aquis-quoted share last week. There was a 38.9% rise to 9.375p, which took the share price back above the 7.5p placing price. The shares started trading on the US OTCQB Venture Market on 26 July. Executive director Howard White bought 55,500 shares at 9p each, taking his stake to 3.89%.

Coinsilium Group Ltd (LON: COIN) has been appointed adviser to Metalinq Labs Inc and it has a token purchase agreement to acquire $200,000 of future Metalinq tokens, which should be issued in 2023. Metalinq is a next generation Layer 3 protocol solution enabling interoperability between metaverses. Existing Indorse token owners (Coinsilium holds 5.35 million Indorse tokens) are eligible to receive Metalinq tokens. The share price jumped 20.4% to 2.95p.

- Advertisement -

==========

Fallers

Shares in Lekoil Ltd (LON: LEK) returned from suspension after the publication of interim results. The share price fell 18.4% to 0.775p. Thanks to finance income Lekoil reported a pre-tax profit of $836,000. Olapade Durotoye is leaving the board to take up a role at Savannah Energy. Lekoil is continuing its litigation with the former chief executive and Lekoil Nigeria.

TECC Capital (LON: TEC) shares fell 9.37% to 2.9p prior to their suspension. TECC Capital is subscribing for £300,000 of convertible loan notes in EDX Medical Ltd, with a reverse takeover expected to eventually happen. This is subject to due diligence. EDX Medical was founded by Sir Chris Evans to develop digital diagnostics products and services. It owns a laboratory in Cambridge and offers testing and genomic sequencing research.

- Advertisement -

AQRU (LON: AQRU) shares declined 6% to 1.175p, having floated as a shell in April 2021 at 5p a share. The decentralised finance company lost £2.32m in the six months to April 2022 and still had net cash of £6.1m.

In the year to March 2022, Oberon Investments (LON: OBE) increased its revenues by 75% to £6.7m. That includes an initial contribution from financial planning business Smythe House. The big increase in revenues came from corporate finance. The pre-tax loss was £581,000, after a £212,500 gain on investments. Funds under management increased by 80% to more than £1bn. The share price fell 5.05% to 4.7p.

Greencare Capital (LON: GRE) is still seeking a suitable cannabis-related acquisition. There is still £679,000 in the bank. The share price fell 1.64% to 30p, which values the company at more than five times its net assets.

Latest News

Subscribe to the UK Investor Magazine email newsletter

Register for our free email newsletter and receive the latest investment news, podcasts, event information and offers.

More Articles Like This